Answers are grounded in this paper and cite their sources.
Since biblical times, healers have sought an adequate therapy for genital herpes—albeit unsuccessfully.1During the last decade, however, research efforts have escalated, fueled in part by three interrelated phenomena: (1) the growing number of herpes sufferers demanding care from their physicians2; (2) increasing knowledge about the basic science of both the herpes simplex virus (HSV) and antiviral pharmacology3; and (3) the spiraling interest of government agencies and pharmaceutical companies as the public health implications and the potential market of those afflicted with herpes became clear. We now may be on the horizon of having a meaningful treatment for genital herpes—yet, at the same time, we must proceed cautiously. The antiviral agent acyclovir offers a genuine ray of hope to patients with herpes—both as an effective treatment and as potential prophylaxis. The report by Reichman and colleagues4in this issue ofThe Journal
No takes yet. Share an insight, caveat, or question.
William L. H. Whittington (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: